Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Phastar, a global biometrics contract research organization (CRO), announced it is offering pro bono support to Medicines Development for Global Health (MDGH), a not-for-profit organization developing medicines for neglected diseases primarily ...
read more
Wednesday, August 04, 2021
PHASTAR, a specialist biometrics contract research organization offering industry-leading data management, data science, statistical consulting and clinical trial reporting services, announced the appointment of Chuck Gelb as Chief Commercial Officer...
read more
Monday, December 05, 2022
PHASTAR has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost.
read more
PHARMASEAL will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trials.
read more
Tuesday, January 25, 2022
Founded in 1997, Phlexglobal provides its industry-leading and innovative electronic Trial Master File platform (PhlexTMF) and services to hundreds of global life sciences companies and AI-enabled automation solutions that allow customers to benefit ...
read more
Thursday, November 28, 2013
Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, today announced it has signed an agreement with Pharmacyclics for the oncology drug IMBRUVICA™ (...
read more
PharmaBlock, announced the opening of its new R&D facility in West Chester, Pennsylvania. The facility expands the company's footprint in the US and enables more efficient process R&D services and fast delivery of clinical-stage GMP projects to ...
read more
Wednesday, September 30, 2020
Pharm-Olam has been selected by the DOD to build capability at military treatment facilities in order to support Phase III clinical trials of one or more lead COVID-19 vaccine candidates.
read more
Pharm-Olam, a global midsized clinical research organization, has completed a change of ownership transaction on Friday June 19, 2020.
read more
ICON plc (NASDAQ: ICLR), today announced that Pfizer and Roche have joined the ADDPLAN® DF Consortium. The consortium was founded in 2013 by Novartis Pharma AG, Janssen Pharmaceuticals Inc., Eli Lilly, and Aptiv Solutions, which is an ICON plc ...
read more
Pergamum AB, a portfolio company of Karolinska Development AB, announced today that the primary safety and tolerability end-point was met in the randomized Phase I/II trial of LL-37 for treatment of venous leg ulcers. The data also show that patients...
read more
Pergamum AB announced today that several end-points were met in a randomized Phase II trial of PXL-01 for prevention of post-surgical adhesions. Karolinska Development AB is the majority owner of Pergamum.
read more
Penn Pharma, a leading global provider of integrated drug development, clinical trial supply and manufacturing services to the international healthcare industry, today announced the completion of potent compound safety training and certification for ...
read more
Tuesday, September 23, 2014
PCI is pleased to announce it has acquired Biotec Services International (Biotec). Biotec is a leading provider of Clinical Trial Services and Temperature Controlled Pharmaceutical Services headquartered in Bridgend, Wales in the United Kingdom. ...
read more
Wednesday, April 10, 2013
The Society for Clinical Research Sites (SCRS) is pleased to announce that President Christine Pierre has been nominated for the Clinical Trial Business Woman of the Year Award. This prestigious award, granted by the Partnerships in Clinical Trials (...
read more